Editas Medicine (EDIT) Other Accumulated Expenses (2015 - 2023)

Editas Medicine (EDIT) has 9 years of Other Accumulated Expenses data on file, last reported at $78000.0 in Q2 2023.

• Quarterly Other Accumulated Expenses fell 97.18% year-over-year to $78000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $78000.0 (down 97.18% YoY) and the FY2022 annual result came in at $1.6 million, up 16.12% from the prior year.
• Other Accumulated Expenses eased to $78000.0 in Q2 2023 per EDIT's latest filing, from $109000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.8 million in Q2 2022 and bottomed at $78000.0 in Q2 2023.
• The 5-year median for Other Accumulated Expenses is $862000.0 (2021), against an average of $991222.2.
• The widest annual swing landed in 2019, when Other Accumulated Expenses soared 364.5%; it then tumbled 97.18% in 2023.
• Tracing EDIT's Other Accumulated Expenses over 5 years: stood at $2.7 million in 2019, then tumbled by 57.87% to $1.1 million in 2020, then advanced by 24.6% to $1.4 million in 2021, then increased by 16.12% to $1.6 million in 2022, then sank by 95.23% to $78000.0 in 2023.
• Per Business Quant, the three latest EDIT Other Accumulated Expenses figures stand at $78000.0 (Q2 2023), $109000.0 (Q1 2023), and $1.6 million (Q4 2022).

Peer Comparison